Dorsey Wright Consumer Staples Technical Leaders (DWCS) ニュース

its about phucking time.

You hit rock bottom.
But, at least you hit something! 🤣🤣🤣🤣🤣🤣🤣🤣
RNVA!!$$????????????????

I posted months ago about the fallout.
We have all heard of the trickle down effect.This country will be in a world of hurt. 

Let me correct you. I was ignorant cause I actually thought you were a good person. I’m no longer ignorant cause I have been able to sit back and watch and I see you got what you truly are now. Ring leader for the pump crew. Leaving a wake of bag holders as you promote scams for criminals.

HOTH...................................................https://stockcharts.com/h-sc/ui?s=HOTH&p=W&b=5&g=0&id=p86431144783

Who gives a **** whether you sell shares or not. Read more and post less.

The only logical explanation is that whoever is getting these new shares that are getting added to the outstanding shares is holding them for one reason or another

1. Price increase
2. Controlling interest
3. Swapped shares from MTi to Affluence??

They

Understand, still seems cheap if this is what people say it is. Pretty big discount, not sure why they would do that. I'm sure the team has a price in mind pending trial results, and that's if they decide to sell down the road.

Hi Max, interesting trading. You have been making money. Congratulations.

Aaaand...right back down. Maybe jumped last night with that 10-K PR.

Maybe Nvidia will use lwlg which maybe is being used by Intel

https://www.tradingview.com/news/barchart:102e600a7094b:0-rumor-has-it-that-nvidia-is-about-to-become-a-major-intel-customer-how-should-you-play-intc-stock-here/

With all the things that are lined up to kick off on approval , NWBO will get plenty of attention through PRs and news media. It will still be talked about at ASCO by others.


The above is only true provided that NWBO wholeheartedly implements a radically different public and i

So, here's the issue/problem with getting a deal done, according to Paul anyway. This is it and what we talked about.

Because our share price is so low and beat down, he thinks we need to get our share price higher to get a GOOD deal done and also for getting higher valuations

Hmmmm numbers do not lie, people do.

sbfm.................................................................................................https://stockcharts.com/h-sc/ui?s=sbfm&p=W&b=5&g=0&id=p86431144783

"If so, then we have 70+ days.....June?"
stop it!

Sorry Gary, but they said they would be a different company "later in the fall", which was last fall. SP is at .23 and they say they are struggling for money. I'm just saying silent strategy doesn't seem to be working. Maybe time to accentuate the pos and downplay some of the neg. Silence here isn't

Over $1 Million in Revenue With Continued Profitability Projected in the First Half of 2025 for High Demand Product in the Homebuilding Sector from Innovative Designs, Inc. (IVDN)

IVDN's Leading Distributor, Built Link Solutions, is Delivering Increasing Order Flow for Superior Evacua

You JUST proved my point...

So whatever happens is going to go exactly in these 2 points that I outlined. And the reason I said no to the last question, is this timeline for uplifting to NASDAQ or acquisition merger in August 26? It's not. The time is very near. We need to work on it

is ach going to end up debased and crushed like an ant, by xrp, or become it's best friend and partner in dominating the world?

So what ever happened to the plastic juice machine in India and other promises.? I smell a rat here !

ADIA mentioned here: https://www.abnewswire.com/pressreleases/stem-cell-innovators-4-companies-advancing-regenerative-medicine_738086.html

ASII NEWS: https://www.otcmarkets.com/stock/ASII/news/story?e&id=3196475

Accredited Solutions (OTC:ASII) Issues Q1 2025 Shareholder Letter

NEW YORK, NY - April 2, 2025 (NEWMEDIAWIRE) - Accredited Solutions, Inc. (OTC: ASII) ("Accredited Solutions" or the "Company"), a t

we're mentioned here: https://www.abnewswire.com/pressreleases/stem-cell-innovators-4-companies-advancing-regenerative-medicine_738086.html